
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. (HRTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HRTX · as of Jun 9, 2026
Key Statistics
Explore Heron Therapeutics, Inc. Data
hrtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 94.7%
The HRTX analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $6.67, representing +1370.46% upside from the current price of $0.45.
Competitors & Peers
hrtx competitorsStock Performance
Full HistoryAbout Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform…
what is heron therapeutics, inc. · hrtx stock overview · heron therapeutics, inc. company profile · who is heron therapeutics, inc. ceo · hrtx NASDAQ · heron therapeutics, inc. headquarters · heron therapeutics, inc. business segments
About Stock Overview & Key Data
Heron Therapeutics, Inc. (HRTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 26, 1987. As of the latest trading session, HRTX stock price is $0.45, with a market capitalization of $71.6M. The stock has returned -78.60% over the past 12 months and -65.11% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Heron Therapeutics, Inc. stock is Buy, with an average 12-month price target of $6.67. In fiscal year 2025, Heron Therapeutics, Inc. reported revenue of $154.9M and net income of -$20.2M. For detailed data — including Heron Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Heron Therapeutics, Inc. (HRTX) stock price is $0.45. The stock is traded on NASDAQ under the ticker symbol HRTX. The 52-week range is $0.42 – $2.30.